Related Experiment Video
Updated: Jul 16, 2026
11:01
Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Published on: September 18, 2015
Still a future for the bare metal stent?
International Journal of Cardiology
|March 16, 2007
Summary
Coronary stenting, a key percutaneous coronary intervention, now surpasses balloon angioplasty due to better outcomes. Drug-eluting stents offer advantages, but bare metal stents remain important for clinical and economic reasons.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Percutaneous coronary intervention (PCI) has advanced significantly, improving patient outcomes.
- Coronary stenting is now the preferred strategy over balloon angioplasty, offering greater immediate success and reduced restenosis rates.
Discussion:
- The evolution of stent technology shows a trend from bare metal stents to drug-eluting stents.
- Drug-eluting stents provide enhanced clinical results compared to their predecessors.
Key Insights:
- Coronary stenting offers superior clinical and angiographic outcomes compared to traditional balloon angioplasty.
- The shift towards drug-eluting stents is driven by their improved efficacy in preventing restenosis.
Outlook:
- Despite the benefits of drug-eluting stents, bare metal stents will likely remain relevant due to clinical and economic considerations.
- Future strategies may involve optimizing the use of both bare metal and drug-eluting stents based on patient-specific factors.
